Not Yet Recruiting
MA-CRC-II-016 SHR-1811
NCT07355764
- Conditions
- Antibody-drug Conjugates, HER2, Targeted Therapy, +1 more
- Locations
-
Not specified
Clinical trial condition
HER2
Explore clinical trials studying HER2. Study availability and eligibility vary by location and protocol.
16 public trials
8 recruiting studies
HER2 trial results
- Conditions
- Breast Cancer, Breast Carcinoma, Breast Diseases, +7 more
- Locations
-
- Research Site Kuwait City, Kuwait
- Research Site Doha, Qatar
- Research Site Mecca, Saudi Arabia
- Research Site Riyadh, Saudi Arabia
NCT03437837
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- Peking University First Hospital Beijing, Beijing Municipality, China
- Peking University People's Hospital Beijing, Beijing Municipality, China
- Affiliated Hospital of Academy of Military Medical Sciences Beijing, Beijing Municipality, China
- Affiliated Union Hospital of Fujian Medical University Fuzhou, Fujian, China
NCT04249440
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
Not specified
NCT01152853
- Conditions
- Advanced Gastric Cancer, HER2
- Locations
-
- Seoul National University Hospital Seoul, South Korea
Active, Not Recruiting
Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer
NCT06178445
- Conditions
- Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +13 more
- Locations
-
- Universitätsklinikum Augsburg Augsburg, Germany
- Charité Universitätsmedizin Berlin, Germany
- Krankenhaus Nordwest (KHNW) Frankfurt, Germany
- Universitätsklinikum Freiburg Freiburg im Breisgau, Germany